AskDoctor
☰
← Back to Rochester Doctors
Photo of STEVEN D. WITTLIN, CONDITIONS TREATED:Growth Hormone Deficiency, Hyperparathyroidism, Hypothyroidism, Autoimmune Thyroid Diseases, Calcium Metabolism Disorders, Hypoparathyroidism, Cushing's Syndrome, Goiter, Polycystic Ovarian Syndrome, Cardiac, Renal, Liver & Pancreas Diseases
TREATMENTS OFFERED: Insulin Pumps & Continuous Glucose Monitoring in ROCHESTER
β˜… 4.0 (113 reviews)

STEVEN D. WITTLIN MD

CONDITIONS TREATED:Growth Hormone Deficiency, Hyperparathyroidism, Hypothyroidism, Autoimmune Thyroid Diseases, Calcium Metabolism Disorders, Hypoparathyroidism, Cushing's Syndrome, Goiter, Polycystic Ovarian Syndrome, Cardiac, Renal, Liver & Pancreas Diseases TREATMENTS OFFERED: Insulin Pumps & Continuous Glucose Monitoring in Rochester

Address: πŸ—ΊοΈ 601 Elmwood Avenue, 3rd Floor, Rochester, NY 14620

Phone: +1-585-275-2901

Website: Visit Website

Insurance Accepted: Aetna Choice POS II, Aetna Managed Choice POS Open Access, Aetna Elect Choice EPO, BCBS Blue Card PPO, CDPHP PPO, Empire PPO, Independent Health Encompass HMO, MVP HMO, Multiplan PPO, PHCS PPO, UHC Choice Plus POS & UHC Navigate POS

Experience: Since 1976

Available Timing

Working hours not explicitly listed. Please call the clinic for availability.

About STEVEN D. WITTLIN

Meet Dr. Steven D. Wittlin, a renowned endocrinologist based in Rochester, NY. With board certifications in Endocrinology, Diabetes, and Metabolism, as well as the American Board of Internal Medicine, Dr. Wittlin is highly qualified. He earned his medical degree from Tel Aviv University and completed his residency in internal medicine at Booth Memorial Medical Center. Following this, he pursued a fellowship in endocrinology at New York University Medical Center. Dr. Wittlin's primary clinical interests include cutting-edge therapies such as insulin pumps and continuous glucose monitoring, in addition to general endocrinology and diabetes care. He also specializes in innovative diabetes treatments, managing postprandial glucose levels, and evaluating cardiovascular risk in diabetes patients.